184 related articles for article (PubMed ID: 18672082)
1. Role of HIV-1 Vpu protein for virus spread and pathogenesis.
Nomaguchi M; Fujita M; Adachi A
Microbes Infect; 2008 Jul; 10(9):960-7. PubMed ID: 18672082
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpu - an ion channel in search of a job.
Strebel K
Biochim Biophys Acta; 2014 Apr; 1838(4):1074-81. PubMed ID: 23831603
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the HIV-1 Vpu protein.
Friborg J; Yao XJ; Boisvert F; Garzon S; Cohen EA
Leukemia; 1994 Apr; 8 Suppl 1():S156-62. PubMed ID: 8152284
[TBL] [Abstract][Full Text] [Related]
5. Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.
Soper A; Juarez-Fernandez G; Aso H; Moriwaki M; Yamada E; Nakano Y; Koyanagi Y; Sato K
Exp Biol Med (Maywood); 2017 Apr; 242(8):850-858. PubMed ID: 28346011
[TBL] [Abstract][Full Text] [Related]
6. Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.
Hout DR; Mulcahy ER; Pacyniak E; Gomez LM; Gomez ML; Stephens EB
Curr HIV Res; 2004 Jul; 2(3):255-70. PubMed ID: 15279589
[TBL] [Abstract][Full Text] [Related]
7. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4
Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD
Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537
[TBL] [Abstract][Full Text] [Related]
8. Interactions of viral protein U (Vpu) with cellular factors.
Guatelli JC
Curr Top Microbiol Immunol; 2009; 339():27-45. PubMed ID: 20012522
[TBL] [Abstract][Full Text] [Related]
9. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
10. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.
Schindler M; Rajan D; Banning C; Wimmer P; Koppensteiner H; Iwanski A; Specht A; Sauter D; Dobner T; Kirchhoff F
Retrovirology; 2010 Jan; 7():1. PubMed ID: 20078884
[TBL] [Abstract][Full Text] [Related]
11. The Vpu protein: new concepts in virus release and CD4 down-modulation.
Ruiz A; Guatelli JC; Stephens EB
Curr HIV Res; 2010 Apr; 8(3):240-52. PubMed ID: 20201792
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.
Goffinet C; Homann S; Ambiel I; Tibroni N; Rupp D; Keppler OT; Fackler OT
J Virol; 2010 Apr; 84(8):4089-94. PubMed ID: 20147395
[TBL] [Abstract][Full Text] [Related]
13. The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism.
Kuhl BD; Cheng V; Donahue DA; Sloan RD; Liang C; Wilkinson J; Wainberg MA
PLoS One; 2011; 6(11):e27660. PubMed ID: 22110710
[TBL] [Abstract][Full Text] [Related]
14. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
Dubé M; Bego MG; Paquay C; Cohen ÉA
Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
[TBL] [Abstract][Full Text] [Related]
15. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma.
Chen J; Tibroni N; Sauter D; Galaski J; Miura T; Alter G; Mueller B; Haller C; Walker BD; Kirchhoff F; Brumme ZL; Ueno T; Fackler OT
PLoS One; 2015; 10(3):e0120434. PubMed ID: 25793728
[TBL] [Abstract][Full Text] [Related]
16. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
McNatt MW; Zang T; Hatziioannou T; Bartlett M; Fofana IB; Johnson WE; Neil SJ; Bieniasz PD
PLoS Pathog; 2009 Feb; 5(2):e1000300. PubMed ID: 19214216
[TBL] [Abstract][Full Text] [Related]
17. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release.
Iwatani Y; Song SK; Wang L; Planas J; Sakai H; Ishimoto A; Cloyd MW
J Gen Virol; 1997 Apr; 78 ( Pt 4)():841-6. PubMed ID: 9129657
[TBL] [Abstract][Full Text] [Related]
19. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
20. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
Van Damme N; Goff D; Katsura C; Jorgenson RL; Mitchell R; Johnson MC; Stephens EB; Guatelli J
Cell Host Microbe; 2008 Apr; 3(4):245-52. PubMed ID: 18342597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
